Bentham Science Logo

Track Your Manuscript:


Current Radiopharmaceuticals

Volume 13, 3 Issues, 2020
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Radiopharmaceuticals, Volume 1 - Number 1







Nanoparticles in Cancer

, 1(1): 30 - 36

Ernest K.J. Pauwels, Kalevi Kairemo, Paola Erba and Kim Bergstrom


DOI: 10.2174/1874471010801010030


99mTc-Labeled Nanobodies: A New Type of Targeted Probes for Imaging Antigen Expression

, 1(1): 37 - 41

Vicky Caveliers, Virna Cortez-Retamozo, Tony Lahoutte, Lea Olive Tchouate Gainkam, Sophie Hernot, Ann Packeu, Filip De Vos, Chris Vanhove, Serge Muyldermans, Patrick De Baetselier and Hilde Revets


DOI: 10.2174/1874471010801010037


Development of Infection and Inflammation Targeting Compounds

, 1(1): 42 - 48

Peter Laverman, Chantal P. Bleeker-Rovers, Frans H.M. Corstens, Otto C. Boerman and Wim J.G. Oyen


DOI: 10.2174/1874471010801010042



Editor-in-Chief

Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
(Northern Ireland)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.77

Advertisement

PLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog